
FDA approves Selarsdi injection as interchangeable with Stelara
Teva Pharmaceuticals and Alvotech have announced that the US Food and Drug Administration (FDA) has approved the Selarsdi (ustekinumab-aekn) injection as interchangeable with reference biologic Stelara (ustekinumab). As of 30 April, Selarsdi is now …